10 Sep 2025 Biotech Stocks Cannabis Stocks Healthcare Stocks Life Sciences Mid Cap Stocks Small Caps Stocks Emyria’s (ASX:EMD) commercial breakthrough in psychedelic medicine When Perth-based Emyria (ASX:EMD) announced on 18 June that Medibank would be funding eligible customer participation in Emyria's Post-Traumatic Stress Disorder care programme, with no out-of-pocket costs, investors who know… ByStuart Roberts